Pravi Moodley

2.6k total citations
94 papers, 1.6k citations indexed

About

Pravi Moodley is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Pravi Moodley has authored 94 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Infectious Diseases, 38 papers in Virology and 35 papers in Epidemiology. Recurrent topics in Pravi Moodley's work include HIV/AIDS Research and Interventions (45 papers), HIV Research and Treatment (38 papers) and HIV/AIDS drug development and treatment (29 papers). Pravi Moodley is often cited by papers focused on HIV/AIDS Research and Interventions (45 papers), HIV Research and Treatment (38 papers) and HIV/AIDS drug development and treatment (29 papers). Pravi Moodley collaborates with scholars based in South Africa, United States and United Kingdom. Pravi Moodley's co-authors include Raveen Parboosing, Neel R. Gandhi, Koleka Mlisana, James C.M. Brust, Salim Allana, Dhayendre Moodley, Angela Campbell, Lewis Haddow, Philippa Easterbrook and Anisa Mosam and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Pravi Moodley

90 papers receiving 1.6k citations

Peers

Countries citing papers authored by Pravi Moodley

Since Specialization

Citations

This map shows the geographic impact of Pravi Moodley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pravi Moodley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pravi Moodley more than expected).

Fields of papers citing papers by Pravi Moodley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pravi Moodley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pravi Moodley. The network helps show where Pravi Moodley may publish in the future.

Co-authorship network of co-authors of Pravi Moodley

This figure shows the co-authorship network connecting the top 25 collaborators of Pravi Moodley. A scholar is included among the top collaborators of Pravi Moodley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pravi Moodley. Pravi Moodley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa 2024 ·Viruses ·(unknown), (unknown), Justen Manasa, Richard Lessells, Andrew Tomita, Melendhran Pillay, (unknown), (unknown), (unknown), Pravi Moodley, Nokukhanya Msomi, Kerusha Govender, Raveen Parboosing, Sikhulile Moyo, Kogieleum Naidoo, Benjamin Chimukangara	3
2	Depression: an individual-level early warning indicator of virologic failure in HIV patients in South Africa 2024 ·Public Health Action ·J. A. Edwards, (unknown), Matthew R. Dudgeon, Chad Robichaux, Brent A. Johnson, (unknown), (unknown), Yan V. Sun, Sureshnee Pillay, Carlos A. Ordóñez, José Castillo‐Mancilla, Frank Tanser, Zahid Asghar, Paul Mee, Pravi Moodley, Henry Sunpath, Daniel R. Kuritzkes, Vincent C. Marconi, (unknown)	0
3	Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy 2023 ·AIDS ·Jienchi Dorward, Katya Govender, Pravi Moodley, Richard Lessells, Natasha Samsunder, Yukteshwar Sookrajh, Thomas Fanshawe, Philip J. Turner, Christopher Butler, Paul K. Drain, Gail Hayward, Nigel Garrett	1
4	Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa 2023 ·Open Forum Infectious Diseases ·(unknown), Lara Lewis, (unknown), Yukteshwar Sookrajh, Thokozani Khubone, Pravi Moodley, Richard Lessells, Kogieleum Naidoo, (unknown), Nigel Garrett, Jienchi Dorward	2
5	Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure 2023 ·AIDS ·Suzanne M. McCluskey, Katya Govender, John Adamson, Monica Gandhi, Matthew A. Spinelli, Mahomed‐Yunus S. Moosa, Winnie Muyindike, Pravi Moodley, Melendhran Pillay, (unknown), Henry Sunpath, (unknown), Geoffrey Chen, Bethany Hedt‐Gauthier, Vincent C. Marconi, Mark J. Siedner	12
6	Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER study 2021 ·BMJ Open ·Jienchi Dorward, Yukteshwar Sookrajh, Hope Ngobese, Richard Lessells, (unknown), (unknown), Pravi Moodley, Natasha Samsunder, Lara Lewis, Sarah Tonkin‐Crine, Paul K. Drain, Gail Hayward, Christopher Butler, Nigel Garrett	7
7	Who’s slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first‐line HIV treatment in Uganda and South Africa 2021 ·HIV Medicine ·Zahra Reynolds, Suzanne M. McCluskey, (unknown), Rebecca F. Gilbert, (unknown), (unknown), Kevin L. Ard, Winnie Muyindike, Nicholas Musinguzi, (unknown), Pravi Moodley, (unknown), (unknown), Gavin George, Brent A. Johnson, Rajesh T. Gandhi, Henry Sunpath, Vincent C. Marconi, Mwebesa Bwana, Mark J. Siedner	2
8	Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa 2021 ·Annals of Internal Medicine ·Mark J. Siedner, Mahomed‐Yunus S. Moosa, Suzanne M. McCluskey, Rebecca F. Gilbert, (unknown), (unknown), Kevin L. Ard, Winnie Muyindike, Nicholas Musinguzi, (unknown), Melendhran Pillay, Pravi Moodley, (unknown), (unknown), Gavin George, Rajesh T. Gandhi, Brent A. Johnson, Henry Sunpath, Mwebesa Bwana, Vincent C. Marconi	13
9	HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral therapy in KwaZulu-Natal Province, South Africa 2021 ·Journal of Global Antimicrobial Resistance ·Benjamin Chimukangara, Richard Lessells, Benn Sartorius, (unknown), (unknown), Melendhran Pillay, Lavanya Singh, Jennifer Giandhari, Kerusha Govender, (unknown), Nokukhanya Msomi, Kogieleum Naidoo, Túlio de Oliveira, Pravi Moodley, Raveen Parboosing	12
10	Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa 2020 ·American Journal of Epidemiology ·Kristin N. Nelson, Neel R. Gandhi, Barun Mathema, Benjamin A. Lopman, James C.M. Brust, Sara C. Auld, Nazir Ismail, Shaheed Vally Omar, Tyler S. Brown, Salim Allana, (unknown), Pravi Moodley, Koleka Mlisana, Neha Shah, Samuel M. Jenness	6
11	Impact of Shifts to Birth Testing on Early Infant Diagnosis Program Outcomes in KwaZulu-Natal, South Africa 2019 ·The Pediatric Infectious Disease Journal ·(unknown), Kerusha Govender, Pravi Moodley, Philip La Russa, Louise Kuhn, Moherndran Archary	4
12	Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models 2019 ·Journal of Medical Economics ·(unknown), Gavin George, Mwebesa Bwana, (unknown), (unknown), Suzanne M. McCluskey, (unknown), Kevin L. Ard, Winnie Muyindike, Pravi Moodley, (unknown), Brent A. Johnson, Rajesh T. Gandhi, Henry Sunpath, Vincent C. Marconi, Mark J. Siedner	1
13	Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa 2019 ·PLoS ONE ·(unknown), Monisha Sharma, Jienchi Dorward, (unknown), (unknown), Pravi Moodley, Natasha Samsunder, Ruanne V. Barnabas, Nigel Garrett, Paul K. Drain	34
14	Short Communication: Early Antiretroviral Therapy Is Associated with Better Viral Suppression and Less HIV Drug Resistance After Implementation of Universal Treatment in South Africa 2019 ·AIDS Research and Human Retroviruses ·Jienchi Dorward, Paul K. Drain, Farzana Osman, Yukteshwar Sookrajh, Melendhran Pillay, Pravi Moodley, Nigel Garrett	13
15	Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa 2017 ·PLoS ONE ·Thandi Kapwata, Natashia Morris, Angela Campbell, Thuli Mthiyane, (unknown), Kristin N. Nelson, Salim Allana, James C.M. Brust, Pravi Moodley, Koleka Mlisana, Neel R. Gandhi, Neha Shah	19
16	Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study 2017 ·BMJ Open ·Jienchi Dorward, Nigel Garrett, Justice Quame‐Amaglo, Natasha Samsunder, Hope Ngobese, (unknown), Pravi Moodley, Koleka Mlisana, Torin Schaafsma, Deborah Donnell, Ruanne V. Barnabas, Kogieleum Naidoo, Salim S. Abdool Karim, Connie Celum, Paul K. Drain	18
17	The SASCM CRE-WG: consensus statement and working guidelines for the screening and laboratory detection of carbapenemase-producing Enterobacteriaceae 2014 ·Southern African Journal of Infectious Diseases ·Warren Lowman, Colleen Bamford, Chetna Govind, (unknown), Ranmini Kularatne, (unknown), Adrian Brink, Pravi Moodley, Juno Thomas, Jesper Smit, Olga Perovic	4
18	Human immunodeficiency virus and hepatitis B or C co-infection in KwaZulu-Natal: a retrospective analysis of a laboratory database 2013 ·Southern African Journal of Infectious Diseases ·(unknown), Raveen Parboosing, Lavanya Singh, C C Jinabhai, Pravi Moodley	2
19	Geographical evolution of the CTX-M -lactamase an update 2007 ·AFRICAN JOURNAL OF BIOTECHNOLOGY ·Usha Govinden, Chunderika Mocktar, Pravi Moodley, (unknown), Sabiha Y. Essack	13
20	Bacterial vaginosis and associated infections in pregnancy 1996 ·International Journal of Gynecology & Obstetrics ·Laurencia Govender, A A Hoosen, (unknown), Pravi Moodley, A. W. Sturm	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact